Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections

URN to cite this document:: urn:nbn:de:bvb:355-epub-268579
DOI to cite this document:: 10.5283/epub.26857

Naber, K. G. ; Kees, Frieder K. ; Grobecker, H.

Preview

PDF
(352kB)

Date of publication of this fulltext: 30 Nov 2012 10:18

Alternative links to fulltext:Pubmed

Details

Preview

Export bibliographical data

Abstract

Thirty-six urological patients (21 male, 15 female) aged 21 to 83 years with complicated and/or hospital-acquired urinary tract infections due to sensitive bacteria were treated with ceftazidime intravenously with a daily dose of 2 g bd over 5 to 17 days. Twenty-seven patients were followed for 1 to 4 weeks after therapy. Cure was observed in 41%, reinfection in 33% and relapse in 26% of the ...